New Consultation on Corporate WVR Beneficiaries and Updated Guidance to Listing Rules for Biotech Companies

22 May 2020
View Debevoise In Depth
Key takeaways:
  • HKEx launches consultation on expanding the availability of weighted voting rights (“WVR”) structures.
  • Updated HKEx guidance on listing suitability criteria for biotech companies.
  • New disclosure requirements for biotech company IPOs.